269 related articles for article (PubMed ID: 37629053)
21. Long-Term Stability of Neuroaxonal Structure in Alemtuzumab-Treated Relapsing-Remitting Multiple Sclerosis Patients.
Chan JK; Hernandez Martínez de Lapiscina E; Taylor C; Nguyen AL; Alba-Arbalat S; Devonshire V; Sayao AL; Carruthers R; Costello F; Traboulsee A
J Neuroophthalmol; 2020 Mar; 40(1):37-43. PubMed ID: 32045393
[TBL] [Abstract][Full Text] [Related]
22. Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study.
Martinez-Lapiscina EH; Arnow S; Wilson JA; Saidha S; Preiningerova JL; Oberwahrenbrock T; Brandt AU; Pablo LE; Guerrieri S; Gonzalez I; Outteryck O; Mueller AK; Albrecht P; Chan W; Lukas S; Balk LJ; Fraser C; Frederiksen JL; Resto J; Frohman T; Cordano C; Zubizarreta I; Andorra M; Sanchez-Dalmau B; Saiz A; Bermel R; Klistorner A; Petzold A; Schippling S; Costello F; Aktas O; Vermersch P; Oreja-Guevara C; Comi G; Leocani L; Garcia-Martin E; Paul F; Havrdova E; Frohman E; Balcer LJ; Green AJ; Calabresi PA; Villoslada P;
Lancet Neurol; 2016 May; 15(6):574-84. PubMed ID: 27011339
[TBL] [Abstract][Full Text] [Related]
23. Association of paramagnetic rim lesions and retinal layer thickness in patients with multiple sclerosis.
Krajnc N; Dal-Bianco A; Leutmezer F; Kasprian G; Pemp B; Kornek B; Berger T; Rommer PS; Hametner S; Lassmann H; Bsteh G
Mult Scler; 2023 Mar; 29(3):374-384. PubMed ID: 36537667
[TBL] [Abstract][Full Text] [Related]
24. Optical coherence tomography as a prognostic tool for disability progression in MS: a systematic review.
Swinnen S; De Wit D; Van Cleemput L; Cassiman C; Dubois B
J Neurol; 2023 Feb; 270(2):1178-1186. PubMed ID: 36372866
[TBL] [Abstract][Full Text] [Related]
25. Retinal ganglion cell loss in neuromyelitis optica: a longitudinal study.
Oertel FC; Havla J; Roca-Fernández A; Lizak N; Zimmermann H; Motamedi S; Borisow N; White OB; Bellmann-Strobl J; Albrecht P; Ruprecht K; Jarius S; Palace J; Leite MI; Kuempfel T; Paul F; Brandt AU
J Neurol Neurosurg Psychiatry; 2018 Dec; 89(12):1259-1265. PubMed ID: 29921610
[TBL] [Abstract][Full Text] [Related]
26. Disease-modifying therapies modulate retinal atrophy in multiple sclerosis: A retrospective study.
Button J; Al-Louzi O; Lang A; Bhargava P; Newsome SD; Frohman T; Balcer LJ; Frohman EM; Prince J; Calabresi PA; Saidha S
Neurology; 2017 Feb; 88(6):525-532. PubMed ID: 28077493
[TBL] [Abstract][Full Text] [Related]
27. Optical coherence tomography reflects brain atrophy in multiple sclerosis: A four-year study.
Saidha S; Al-Louzi O; Ratchford JN; Bhargava P; Oh J; Newsome SD; Prince JL; Pham D; Roy S; van Zijl P; Balcer LJ; Frohman EM; Reich DS; Crainiceanu C; Calabresi PA
Ann Neurol; 2015 Nov; 78(5):801-13. PubMed ID: 26190464
[TBL] [Abstract][Full Text] [Related]
28. Relationship Between Retinal Layer Thickness and Disability Worsening in Relapsing-Remitting and Progressive Multiple Sclerosis.
Cellerino M; Priano L; Bruschi N; Boffa G; Petracca M; Novi G; Lapucci C; Sbragia E; Uccelli A; Inglese M
J Neuroophthalmol; 2021 Sep; 41(3):329-334. PubMed ID: 33399416
[TBL] [Abstract][Full Text] [Related]
29. Peripapillary retinal nerve fiber layer thickness measured by optical coherence tomography in different clinical subtypes of multiple sclerosis.
Jankowska-Lech I; Wasyluk J; Palasik W; Terelak-Borys B; Grabska-Liberek I
Mult Scler Relat Disord; 2019 Jan; 27():260-268. PubMed ID: 30423530
[TBL] [Abstract][Full Text] [Related]
30. Optical coherence tomography reflects clinically relevant gray matter damage in patients with multiple sclerosis.
Cagol A; Fuertes NC; Stoessel M; Barakovic M; Schaedelin S; D'Souza M; Würfel J; Brandt AU; Kappos L; Sprenger T; Naegelin Y; Kuhle J; Granziera C; Papadopoulou A
J Neurol; 2023 Apr; 270(4):2139-2148. PubMed ID: 36625888
[TBL] [Abstract][Full Text] [Related]
31. Serious infections in patients with relapsing and progressive forms of multiple sclerosis: A German claims data study.
Knapp R; Hardtstock F; Krieger J; Wilke T; Maywald U; Chognot C; Muros-Le Rouzic E; Craveiro L
Mult Scler Relat Disord; 2022 Dec; 68():104245. PubMed ID: 36306609
[TBL] [Abstract][Full Text] [Related]
32. Association of Spectral-Domain OCT With Long-term Disability Worsening in Multiple Sclerosis.
Lambe J; Fitzgerald KC; Murphy OC; Filippatou AG; Sotirchos ES; Kalaitzidis G; Vasileiou E; Pellegrini N; Ogbuokiri E; Toliver B; Luciano NJ; Davis S; Fioravante N; Kwakyi O; Risher H; Crainiceanu CM; Prince JL; Newsome SD; Mowry EM; Saidha S; Calabresi PA
Neurology; 2021 Apr; 96(16):e2058-e2069. PubMed ID: 33653904
[TBL] [Abstract][Full Text] [Related]
33. Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis.
Petzold A; Balcer LJ; Calabresi PA; Costello F; Frohman TC; Frohman EM; Martinez-Lapiscina EH; Green AJ; Kardon R; Outteryck O; Paul F; Schippling S; Vermersch P; Villoslada P; Balk LJ;
Lancet Neurol; 2017 Oct; 16(10):797-812. PubMed ID: 28920886
[TBL] [Abstract][Full Text] [Related]
34. Optical Coherence Tomography in Chronic Relapsing Inflammatory Optic Neuropathy, Neuromyelitis Optica and Multiple Sclerosis: A Comparative Study.
Eslami M; Lichtman-Mikol S; Razmjou S; Bernitsas E
Brain Sci; 2022 Aug; 12(9):. PubMed ID: 36138876
[TBL] [Abstract][Full Text] [Related]
35. The Temporal Retinal Nerve Fiber Layer Thickness Is the Most Important Optical Coherence Tomography Estimate in Multiple Sclerosis.
Birkeldh U; Manouchehrinia A; Hietala MA; Hillert J; Olsson T; Piehl F; Kockum IS; Brundin L; Zahavi O; Wahlberg-Ramsay M; Brautaset R; Nilsson M
Front Neurol; 2017; 8():675. PubMed ID: 29326643
[TBL] [Abstract][Full Text] [Related]
36. Multiple sclerosis optic neuritis and trans-synaptic pathology on cortical thinning in people with multiple sclerosis.
Ganapathy Subramanian R; Zivadinov R; Bergsland N; Dwyer MG; Weinstock-Guttman B; Jakimovski D
J Neurol; 2023 Aug; 270(8):3758-3769. PubMed ID: 37067590
[TBL] [Abstract][Full Text] [Related]
37. Optical coherence tomography with voxel-based morphometry: a new tool to unveil focal retinal neurodegeneration in multiple sclerosis.
Huang SC; Pisa M; Guerrieri S; Dalla Costa G; Comi G; Leocani L
Brain Commun; 2024; 6(1):fcad249. PubMed ID: 38328398
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of Retinal Layer Thickness Parameters as Biomarkers in a Real-World Multiple Sclerosis Cohort.
Schurz N; Sariaslani L; Altmann P; Leutmezer F; Mitsch C; Pemp B; Rommer P; Zrzavy T; Berger T; Bsteh G
Eye Brain; 2021; 13():59-69. PubMed ID: 33737853
[TBL] [Abstract][Full Text] [Related]
39. Effects of Myopia on Rates of Change in Optical Coherence Tomography Measured Retinal Layer Thicknesses in People with Multiple Sclerosis and Healthy Controls.
Kalaitzidis G; Pellegrini N; Nagy N; Vasileiou E; Ehrhardt H; Reppen A; Murphy OC; Moussa H; Filippatou A; Lambe J; DuVal A; Fioravante N; Kwakyi O; Nguyen J; Davis S; Douglas M; Ramirez A; Ecoff K; Valenzuela A; Reyes-Mantilla M; Hu C; Fitzgerald KC; Sotirchos ES; Saidha S; Calabresi PA
Curr Eye Res; 2023 Mar; 48(3):312-319. PubMed ID: 36440535
[TBL] [Abstract][Full Text] [Related]
40. Retinal ganglion cell loss is associated with future disability worsening in early relapsing-remitting multiple sclerosis.
Wauschkuhn J; Solorza Buenrostro G; Aly L; Asseyer S; Wicklein R; Hartberger JM; Ruprecht K; Mühlau M; Schmitz-Hübsch T; Chien C; Berthele A; Brandt AU; Korn T; Paul F; Hemmer B; Zimmermann HG; Knier B
Eur J Neurol; 2023 Apr; 30(4):982-990. PubMed ID: 36635219
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
